|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 234.30 EUR | -0.59% |
|
-6.28% | -1.80% |
| Jul. 14 | Where would AI lead Pharma in the long run? | ![]() |
| Jul. 13 | Antengene Receives $60 Million Milestone in UCB Licensing Deal | MT |
| Market Cap | 44.87B 51.32B 41.39B 38.05B 72.09B 4,938B 73.32B 494B 194B 2,414B 193B 188B 8,319B | P/E 2026 * |
25.3x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 44.6B 51.01B 41.14B 37.82B 71.66B 4,908B 72.88B 491B 193B 2,399B 192B 187B 8,269B | EV / Sales 2026 * |
5.22x | EV / Sales 2027 * | 4.42x |
| Free-Float |
61.59% | Yield 2026 * |
0.62% | Yield 2027 * | 0.64% |
Last Transcript: UCB
| 1 day | -0.59% | ||
| 1 week | -6.28% | ||
| Current month | -10.57% | ||
| 1 month | -6.28% | ||
| 3 months | -9.43% | ||
| 6 months | -11.78% | ||
| Current year | -1.80% |
| 1 week | 230.7 | 253.4 | |
| 1 month | 230.7 | 268.3 | |
| Current year | 223 | 289.5 | |
| 1 year | 169.35 | 289.5 | |
| 3 years | 65.4 | 289.5 | |
| 5 years | 65.4 | 289.5 | |
| 10 years | 54.84 | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jan. 14 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| Jan. 14 | Buy | Director | 500 | 0.0003% | ||
| Jan. 14 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.59% | -6.28% | +38.11% | +192.29% | 51.32B | ||
| +1.27% | +0.24% | +21.26% | -7.53% | 67.6B | ||
| +1.10% | +38.30% | +38.30% | +38.30% | 42.97B | ||
| +0.16% | -2.85% | -50.72% | -52.88% | 40.81B | ||
| +2.76% | -1.56% | +54.70% | -29.29% | 29.12B | ||
| +1.25% | -7.48% | +116.21% | -43.73% | 27.09B | ||
| +0.18% | -1.85% | +68.63% | +86.35% | 22.99B | ||
| -2.94% | +9.09% | +9.28% | +199.05% | 21.55B | ||
| +3.84% | -1.00% | +67.49% | +130.32% | 16.38B | ||
| -1.70% | +5.53% | +76.00% | +353.68% | 16.2B | ||
| Average | +0.47% | +0.00% | +43.93% | +86.66% | 33.6B | |
| Weighted average by Cap. | +0.55% | -0.47% | +35.19% | +62.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.54B 9.77B 7.88B 7.24B 13.72B 940B 13.95B 94.04B 36.9B 459B 36.68B 35.87B 1,583B | 9.64B 11.02B 8.89B 8.17B 15.48B 1,061B 15.75B 106B 41.64B 518B 41.39B 40.49B 1,787B |
| Net income | 1.77B 2.02B 1.63B 1.5B 2.84B 194B 2.88B 19.44B 7.63B 94.96B 7.58B 7.42B 327B | 2.27B 2.6B 2.1B 1.93B 3.65B 250B 3.72B 25.04B 9.82B 122B 9.77B 9.55B 422B |
| Net Debt | -271M -310M -250M -230M -436M -29.86B -443M -2.99B -1.17B -14.59B -1.17B -1.14B -50.3B | -2.31B -2.65B -2.13B -1.96B -3.72B -255B -3.78B -25.47B -10B -124B -9.94B -9.72B -429B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | €234.30 | -0.59% | 11,854 |
| 26-07-15 | €235.70 | +1.38% | 167,608 |
| 26-07-14 | €232.50 | -1.32% | 152,960 |
| 26-07-13 | €235.60 | -0.63% | 192,311 |
| 26-07-10 | €237.10 | -5.16% | 222,991 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Select your edition
All financial news and data tailored to specific country editions




















